Log in to save to my catalogue

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma:...

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1291064230

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

About this item

Full title

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

Publisher

United States: Public Library of Science

Journal title

PloS one, 2009-07, Vol.4 (7), p.e6341-e6341

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Although most classical Hodgkin lymphoma patients are cured, a significant minority fail after primary therapy and may die as result of their disease. To date, there is no consensus on biological markers that add value to usual parameters (which comprise the International Prognostic Score) used at diagnosis to predict outcome. We evaluated 59 patie...

Alternative Titles

Full title

Prognostic Significance of New Immunohistochemical Markers in Refractory Classical Hodgkin Lymphoma: A Study of 59 Cases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1291064230

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1291064230

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0006341

How to access this item